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Background
Chances are, we all know someone who has
had their life affected by depression and
anxiety; and we have all experienced these
feelings on some level. What if the key to
unlocking these problems lied within every
one of us -- inside of our gut? The research
topic being explored is the relationship
between gut health and mood disorders. The
question of interest is: Does the use of
probiotic supplementation have an effect on
feelings of depression?

Proposal For Further Study
Randomized Control Trials:
Probiotic Lactobacillus
plantarum P8 alleviated
stress and anxiety while
enhancing memory and
cognition in stressed adults
(2018)

Connection between gut health and mental
health is significant as approximately 6.7%
of adults in the U.S. suffer from major
depressive disorder. There has been an
observed association between gut health
disorders and mood disorders, mainly
anxiety and depression. Those who
demonstrate anxiety and depression have an
increased likelihood of developing abnormal
gastrointestinal (GI) symptoms. This raises
the possibility of bi-directionality between
the brain and the gut, meaning that GI
health may have an effect on mental health
and vice versa.
This relationship is important to explore.
Probiotics, bacteria that are beneficial to
the body, have grown in popularity as a gut
health supplement which may have an affect
on the brain. There is much reason to
suspect and explore the relationship
between probiotic supplements and
depression.

Search Strategies
Multiple peer-reviewed journals found through the
Dominican University library databases:
ScienceDirect and CINAHL.
Eight articles were selected to give a holistic view
of the brain-gut pathway and how probiotics affect
the brain.
Key search terms: probiotics, correlation,
depression

Stress matters: Randomized
controlled trial on the
effect of probiotics on
neurocognition (2019)

Goal of the experiment was to investigate effects of probiotics (Lactobacillus plantarum P8)
on the alleviation of stress in stressed adults. Subjects were tested for psychological distress
using the Perceived Stress Scale questionnaire,and the Depression, Anxiety, and Stress Scale
(DASS-42), every four weeks. Memory and cognitive functions were tested at baseline and
periodically thereafter. During week 4, 8, and 12 the P8 group had much lower stress than
the control. The DASS-42 attributes this to reduction of “touchiness”, reduced irritation,
increased calmness, and increased tolerance against interruptions. This shows that L.
plantarum P8 may have a potential future as an anxiolytic supplement.

Research team set out to investigate effects on neurocognitive measures of emotion. They
wanted to test whether probiotics could be used to buffer against the effects of stress on
memory in a randomized, double blind, placebo-controlled trial.These results indicated that
the group taking probiotics had developed a larger buffer against the negative effects of
stress on their memory.

Original Research: Probiotic
Bifidobacterium longum
NCC3001 Reduces
Depression Scores and
Alters Brain Activity: A Pilot
Study in Patients With
Irritable Bowel Syndrome
(2017)

Conducted research on the probiotic Bifidobacterium longum NCC3001 to evaluate its
effects on anxiety and depression for patients with irritable bowel syndrome. Anxiety and
depression were analyzed by the Hospital Anxiety and Depression Scale. Blood, stool, and
urine samples were collected.. MRIs were used to assess brain activity. At 6 weeks, the
patients in the B. longum group had decreased depression compared to the placebo group.
No changes were found for patients with anxiety. Depression and anxiety are related to
amygdala hyperactivity but both SSRIs and B. longum were able to benefit the patient by
decreasing its activity. This shows how probiotics may be able to take a stand in the world
of antidepressants.

Effect of Lactobacillus
rhamnosus HN001 in
Pregnancy on Postpartum
Symptoms of Depression
and Anxiety: A Randomised
Double-blind Placebocontrolled Trial (2017)

Evaluate the effects of bacteria on maternal anxiety and depression during postpartum
period.The Edinburgh Postnatal Depression Scale and State Trait Anxiety Inventory was used
to help mothers describe their psychological wellbeing from when their child was 1 to 2
months old. This was done at 6 or 12 months postpartum. Number of women who reported
clinically significant depression above the standard cut-off did not differ between the
HN001 group and the placebo group. However, women receiving the HN001 treatment were
significantly less likely to have anxiety above the cut-off point.

Conclusions
The primary question of interest, “does the use of probiotic supplementation have an effect
on feelings of depression?” was answered. Effects of these bacteria caninclude relief of
depressive symptoms along with relief from stress and anxiety. Lactobacillus plantarum P8,
Bifidobacterium longum NCC300, and Lactobacillus rhamnosus HN001 are three specific
probiotic strains that have demonstrated effects on depression and anxiety. Findings show
that different probiotics have different effects on the mind.
Health care professionals can develop new ways of treating depression and anxiety. When a
patient is newly diagnosed with depression, the use of psychotherapy and probiotics could be
the first line of treatment before switching to pharmaceutical drugs like selective serotonin
reuptake inhibitors. Perhaps probiotics will be so well-studied that they become the more
natural solution to mental health crises and replace pharmaceuticals as the standard of care.

Question of Interest
Which probiotic decreases symptoms of
depression in the fastest and most
significant way - Bifidobacterium longum
NCC300, Lactobacillus plantarum P8, or
both?
Sampling
A minimum sample of 500 patients age
18-65 who have been diagnosed with
depression.
Methods
This is a randomized, double-blind,
placebo-controlled study. Subjects will be
interviewed at baseline and depression
scores will be evaluated using the
Depression, Anxiety and Stress Scale 42
and Beck Depression Inventory II.
Subjects will then be randomized and
receive either control, Bifidobacterium
longum NCC300, Lactobacillus plantarum
P8 group, or the combination group.
Subjects will be instructed to take their
sample every day at approximately the
same time each morning. Depression
scores will be reevaluated using the same
scales at 6 weeks and 12 weeks.
Analysis
In order to analyze the data
from the four groups;
NCC300, P8, combination,
and placebo; a one-way
analysis of variance (ANOVA)
should be performed. This
form of analysis can be used
to determine whether there
are statistically significant
differences between the
four groups.

